Nottingham, United Kingdom

Mark Mills

USPTO Granted Patents = 7 

Average Co-Inventor Count = 7.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mark Mills

Introduction

Mark Mills is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of neuroscience through his innovative work. With a total of seven patents to his name, Mills has focused on developing compounds that target orexin receptors, which play a crucial role in various neurological and psychiatric disorders.

Latest Patents

Mills' latest patents include novel compounds known as Orexin 1 receptor antagonists. These compounds are defined by specific formulas and their salts, which are designed to treat, prevent, ameliorate, control, or reduce the risk of neurological or psychiatric disorders associated with orexin receptors. His work in this area has the potential to impact the treatment of various conditions significantly.

Career Highlights

Throughout his career, Mark Mills has worked with several prominent companies, including Corcept Therapeutics Incorporated and Nxera Pharma UK Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.

Collaborations

Mills has collaborated with notable colleagues such as Andrew William Phillips and Hazel Joan Hunt. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of his work.

Conclusion

Mark Mills is a distinguished inventor whose work on Orexin 1 receptor antagonists showcases his commitment to advancing medical science. His contributions have the potential to improve the lives of many individuals affected by neurological and psychiatric disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…